BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 28, 2014
View Archived Issues
A non-cancerous FGF-19 variant for the treatment of liver disease
Read More
Panther secures option agreement on numonafide with Northwestern University
Read More
Targazyme receives SBIR award to study TZ-101-treated stem cell therapy in oral mucositis
Read More
Avanir initiates phase II study of AVP-786 in major depressive disorder; updates on AVP-923
Read More
Scientists in the U.S. patent novel inhibitors of Rho GTPase activation
Read More
New NS5B inhibitors prepared by Merck & Co.
Read More
Sientists at Cortendo patent new cytochrome P450 inhibitors
Read More
Identification of a transporter protein central to the erythrocytic cycle in Plasmodium parasites
Read More
Actinogen to acquire Corticrine
Read More
Saniona extends collaboration with Janssen Pharmaceutica
Read More
Velphoro receives marketing authorization in Europe
Read More
Merck & Co. divulges new mGlu4R PAMs
Read More
Takeda Pharmaceutical describes new M4 receptor agonists
Read More
Novel class of pan-pim inhibitors as potential oncolytics presented by Amgen
Read More
Live cell encapsulation technology plus low dose anticancer drugs, a novel approach
Read More
Bellcium Pharmaceuticals completes Series C financing
Read More
RedHill Biopharma amends protocol for phase III H. pylori study of RHB-105
Read More
FDA grants priority review to ivabradine for chronic heart failure
Read More
MEDI-6383 to be evaluated in phase I trial in patients with solid tumors
Read More
FDA grants orphan drug status to Iressa and Zelboraf for cancer
Read More
DC Bead approved in China for tumor embolization
Read More
Second DSMB review recommends continuation of GRASPA-ML study
Read More
Biothera receives NIH grant to continue development of antifungal vaccine
Read More
European Commission approves Bristol-Myers Squibb's Daklinza for HCV
Read More
Repros Therapeutics' Androxal superior to AndroGel in pivotal phase III trial in hypogonadism
Read More